Travere therapeutics CEO Eric Dube sells shares for $208,922
Eric Dube, the Chief Executive Officer of Travere Therapeutics Inc. (NASDAQ:TVTX), recently executed a sale of company stock, according to a filing with the Securities and Exchange Commission. On ...
Barchart on MSN57m
What to Expect From Verisk Analytics’ Q4 2024 Earnings Report
Jersey City, New Jersey-based Verisk Analytics, Inc. (VRSK) provides data analytics and technology solutions to the insurance markets. Valued at a market cap of $39.4 billion, the company offers ...